This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
The Procter & Gamble Company: Investment in Crest Whitestrips Advanced Seal
Schill, Michael J.; Lentz, DanielCase DARDEN-F-1670-EFinanceA financial analyst for Procter & Gamble must report on the prospects and implications of a new teeth-whitening product. Beyond a realistic profit-and-loss forecast and baseline net present value, he must determine which pricing and marketing strategy is most likely to maximize value for shareholders.Starting at €8.20
-
The Procter & Gamble Company: Investment in Crest Whitestrips Advanced Seal - Teaching Note
Schill, Michael J.Teaching Note DARDEN-F-1670TN-EFinanceTeaching note for product F-1670Starting at €0.00
-
General Electric, 1984 (Spanish Version)
Aguilar, Francis J.; Hamermesh, Richard G.; Brainard, Caroline E.Case HBS-302S36Knowledge and CommunicationDescribe los primeros cuatro años de permanencia de Jack Welch como CEO de las ofertas de General Electric Co. con las formas Welch ha tratado de actividades de estrategia y planificación del cambio de GE y sus intentos de hacer la empresa más empresarial.Starting at €8.20
-
Shamrock Capital: Pricing the Masters of Taylor Swift
Schill, Michael J.Case DARDEN-F-2050-EFinanceThis case examines the 2020 pricing decision for the master recordings of Taylor Swift’s first six albums in consideration of a sale of the recordings by music executive Scooter Braun to Shamrock Capital (Shamrock), an investment company owned by the Roy E. Disney family. Swift, the most listened-to musician in the world, had expressed displeasure with Braun’s ownership of her masters and a desire to own the recordings herself—even threatening to...Starting at €8.20
-
Bloodbuy
Hamermesh, Richard G.; Norris, MichaelCase HBS-815114-EEntrepreneurshipIn 2015, Chris Godfrey, founder and CEO of Bloodbuy has to consider the best path to growth for his young company that is attempting to disrupt the blood donation industry.Starting at €8.20
-
Amylin Pharmaceuticals B
Hamermesh, Richard G.; Knoop, Carin-IsabelCase HBS-813091-EEntrepreneurshipSupplement for case 809011Starting at €8.20
-
Novasys Medical
Hamermesh, Richard G.; Barley, LaurenCase HBS-810027-EEntrepreneurshipNovasys has developed a new medical device and procedure for the treatment of female stress urinary incontinence that is cheaper and can be performed in doctors' offices. In spite of FDA approval, the American Medical Association has been unwilling to approve the product for reimbursement. The case deals with the company's struggle to obtain a reimbursement code.Starting at €8.20
-
Impact Investing for Cancer
Hamermesh, Richard G.; Preble, MatthewCase HBS-818068-EStrategyStarting at €8.20
-
Bloodbuy, Teaching Plan
Hamermesh, Richard G.; Quelch, John A.; Norris, MichaelTeaching Note HBS-815140-EEntrepreneurshipTeaching plan for case 815114.Starting at €0.00
-
DentalCorp, Teaching Note
Hamermesh, Richard G.; Seefeld, ErinTeaching Note HBS-807163-EEntrepreneurshipTeaching Note to (806-023).Starting at €0.00